Illumina Inc (ILMN.OQ)

ILMN.OQ on NASDAQ Stock Exchange Global Select Market

5 Oct 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ILMN.OQ


Illumina, Inc. is engaged in production development of sequencing-and array-based solutions for genetic analysis. The Company offers integrated systems, consumables and analysis tools for genetic analysis. It also manufactures sequencing and array platforms, reagent kits and scanning equipment. Its customers include genomic... (more)


Beta: 0.96
Market Cap(Mil.): $23,610.70
Shares Outstanding(Mil.): 144.70
Dividend: --
Yield (%): --


  ILMN.OQ Industry Sector
P/E (TTM): 49.89 14.38 32.90
EPS (TTM): 3.27 -- --
ROI: 18.11 2.88 14.19
ROE: 33.79 2.88 15.12
Search Stocks

BRIEF-Inno-Gene signs investment deal with International Technology Ventures

* Signs investment deal with US-based International Technology Ventures, LLC (ITV)

09 Sep 2015

Illumina partners with private equity firm on gene JV: sources

- Gene-sequencing giant Illumina Inc, private equity firm Warburg Pincus LLC and venture capital firm Sutter Hill Ventures have agreed to invest $100 million to seed a new consumer-facing human genome platform called Helix, according to people familiar with the deal.

18 Aug 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Stock Traders Daily
Provider : Wright Reports
Provider : New Constructs, LLC
Provider : ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks